| Literature DB >> 29234177 |
Sarah O Nwozo1, Yetunde T Lewis2, Babatunji E Oyinloye2.
Abstract
BACKGROUND: Piper guineense (PG) and Sesamum indicum (SI) have been shown to be rich sources of antioxidants and other health benefits; hence, we evaluated the impact of its consumption in hypercholesterolemic model on lipid metabolism.Entities:
Keywords: Antioxidants; Hypercholesterolemia; Hyperlipidemias; Piper guineense; Sesamum indicum
Year: 2017 PMID: 29234177 PMCID: PMC5722962
Source DB: PubMed Journal: Iran J Med Sci ISSN: 0253-0716
Comparison of effects of Piper guineense (PG), Sesamum indicum (SI), Cholesterol (CH) and Questran (Q) on the body/organ weights and liver index
| Group | Initial body weight (IBWT) | Final body weight (FBWT) | Weight gain (WG) | Liver weight (LG) | Liver index (LINX) |
|---|---|---|---|---|---|
| CTRL | 101±3.0 | 130±16.7 | 29±16.7 | 3.9±0.7 | 3.8±0.3 |
| QU | 106±13.9 | 139±20.7 | 33±18.3 | 4.5±1.1 | 3.5±0.3 |
| CH | 116±9.6 | 238±27.8 | 122±20.8 | 7.5±0.8 | 2.9±0.6 |
| CHQU | 106±19.19 | 165±28.5 | 59±14.8 | 6.9±0.6 | 3.8±0.9 |
| CHPG (1) | 118±8.4 | 145±13.2 | 27±11.5 | 7.1±1.5 | 4.9±0.7 |
| CHPG (2) | 127±2.7 | 153±33.3 | 26±31.7 | 7.2±1.2 | 4.8±0.4 |
| CHSI (1) | 118±7.6 | 146±15.2 | 28±17.5 | 7.8±0.5 | 5.4±0.4 |
| CHSI (2) | 110±8.2 | 153±10.8 | 43±7.5 | 7.2±0.9 | 3.7±0.3 |
Multiple-comparison of data in table 1 (P levels)
| MComp | Groups | ||||||
|---|---|---|---|---|---|---|---|
| QU | CH | CHQU | CHPG (1) | CHPG (2) | CHSI (1) | CHSI (2) | |
| IBWT | |||||||
| QU | 0.321 | 0.587 | 0.033 | 0.859 | 0.872 | 0.979 | |
| CHPG (1) | 0.022 | 0.047 | 0.031 | ||||
| FBWT | |||||||
| CTRL | 0.258 | 0.304 | 0.558 | 0.020 | 0.312 | 0.005 | 0.278 |
| CHQU | 0.074 | 0.667 | 0.021 | 0.165 | |||
| WG | |||||||
| CH | 0.123 | 0.010 | 0.005 | 0.003 | 0.023 | ||
| CTRL | 0.228 | 0.102 | 0.026 | 0.485 | 0.029 | 0.375 | 0.907 |
| LW | |||||||
| CHQU | 0.115 | 0.96 | 0.164 | 0.034 | |||
| CHPG (2) | 0.179 | 0.038 | |||||
| LINX | |||||||
| QU | 0.12 | 0.08 | 0.359 | 0.994 | 0.624 | 0.023 | |
| CHPG (2) | 0.629 | 0.023 | |||||
Significant at P<0.05
Comparison of effects of Piper guineense (PG), Sesamum indicum (SI), Cholesterol (CH) and Questran (Q) on protein (PROT), total cholesterol (TCH), HDLc, triglyceride, lipid peroxidation
| Group | Protein (mg/100mL) | Triglyceride (mg/dL) | TCH (mg/dL) | Lipid peroxidation (mg/dL) | HDLc (mg/dL) |
|---|---|---|---|---|---|
| CTRL | 1.2±0.2 | 2.1±0.3 | 4.7±0.4 | 27.3±1.6 | 1.8±0.2 |
| QU | 1.2±0.1 | 3.8±0.3 | 2.9±1.6 | 29.3±1.9 | 5.2±1.2 |
| CH | 0.8±0.4 | 3.8±0.9 | 4.9±1.8 | 80.5±2.2 | 2.4±0.5 |
| CHQU | 1.4±0.2 | 2.3±0.7 | 4.1±0.1 | 54.5±2.7 | 4.3±2.2 |
| CHPG (1) | 1.5±0.8 | 2.2±0.1 | 3.3±0.4 | 66.2±1.0 | 6.3±2.8 |
| CHPG (2) | 1.4±0.2 | 2.5±0.1 | 3.3±0.3 | 50.1±2.8 | 5.5±1.0 |
| CHSI (1) | 1.7±0.7 | 2.6±0.2 | 3.9±0.7 | 62.6±1.9 | 12.1±1.9 |
| CHSI (2) | 1.7±0.2 | 1.5±0.2 | 3.5±0.4 | 51.4±2.5 | 7.9±0.8 |
Multiple-comparison for table 3 (P levels)
| MComp | Groups | ||||||
|---|---|---|---|---|---|---|---|
| QU | CH | CHQU | CHPG (1) | CHPG (2) | CHSI (1) | CHSI (2) | |
| PROT | |||||||
| CHPG (1) | 0.415 | 0.007 | 0.055 | ||||
| CHPG (2) | 0.049 | 0.257 | |||||
| TRIG | |||||||
| QU | 0.1 | 0.111 | 0.138 | 0.079 | 0.147 | 0.019 | |
| LPO | |||||||
| CTRL | 0.957 | 0.002 | 0.749 | 0.269 | 0.066 | 0.453 | 0.59 |
| QU | 0.002 | 0.709 | 0.247 | 0.059 | 0.486 | 0.554 | |
| CH | 0.006 | 0.04 | 0.183 | 0.000 | 0.010 | ||
| CHPG (2) | 0.012 | 0.185 | |||||
| CHSI (1) | 0.201 | ||||||
| HDLc | |||||||
| CTRL | 0.42 | 0.846 | 0.86 | 0.234 | 0.325 | 0.000 | 0.087 |
| QU | 0.539 | 0.327 | 0.696 | 0.858 | 0.001 | 0.352 | |
| CH | 0.711 | 0.317 | 0.429 | 0.000 | 0.126 | ||
| CHQU | 0.173 | 0.248 | 0.000 | 0.06 | |||
| CHPG (1) | 0.832 | 0.004 | 0.587 | ||||
| CHPG (2) | 0.002 | 0.451 | |||||
| CHSI (1) | 0.017 | ||||||
Significant at P<0.05
Comparison of effects of Piper guineense (PG), Sesamum indicum (SI), Cholesterol (CH) and Questran (Q) on AST, ALT, CAT, GSH, GST and SOD
| Group | Serum AST (mg/dL) | Serum ALT (mg/dL) | CAT activity (unit/mg protein) | GSH (µg/mL) | GST activity (µmol/mg protein) | SOD activity (unit/mg protein) |
|---|---|---|---|---|---|---|
| CTRL | 8.0±0.5 | 30.2±1.5 | 5.3±0.4 | 2.8±0.3 | 26.2±0.1 | 9.0±2.8 |
| QU | 8.0±1.2 | 34.1±1.3 | 6.2±0.6 | 4.0±0.7 | 31.1±0.1 | 9.0±1.8 |
| CH | 20.7±1.5 | 45.5±3.0 | 3.8±0.6 | 2.1±0.1 | 18.1±0.3 | 2.0±2.1 |
| CHQU | 6.0±0.2 | 24.0±1.3 | 4.1±0.7 | 3.2±1.4 | 28.4±0.3 | 6.0±1.3 |
| CHPG (1) | 12.1±1.9 | 36.5±2.7 | 3.3±0.5 | 4.8±1.4 | 22.1±0.2 | 4.0±1.0 |
| CHPG (2) | 6.6±0.2 | 31.9±5.0 | 3.2±0.4 | 5.5±0.7 | 27.1±0.2 | 7.0±0.9 |
| CHSI (1) | 6.5±4.7 | 38.3±1.8 | 3.2±0.3 | 4.1±1.6 | 25±0.2 | 4.0±2.8 |
| CHSI (2) | 5.0±1.4 | 35.3±2.1 | 3.5±0.1 | 3.9±0.4 | 28.1±0.1 | 6.0±2.2 |
Multiple-comparison for table 5 (P levels)
| MComp | Groups | ||||||
|---|---|---|---|---|---|---|---|
| QU | CH | CHQU | CHPG (1) | CHPG (2) | CHSI (1) | CHSI (2) | |
| AST | |||||||
| CTRL | 0.86 | 0.041 | 0.701 | 0.185 | 0.477 | 0.851 | 0.736 |
| ALT | |||||||
| 0.017 | 0.452 | 0.007 | 0.062 | 0.019 | |||
| CHPG (1) | 0.045 | 0.252 | 0.099 | ||||
| CAT | |||||||
| QU | 0.102 | 0.017 | 0.015 | 0.16 | 0.002 | 0.036 | |
| GSH | |||||||
| CTRL | 0.18 | 0.845 | 0.424 | 0.024 | 0.329 | 0.496 | 0.456 |
| CH | 0.321 | 0.015 | 0.243 | 0.382 | 0.348 | ||
| GST | |||||||
| CHPG (1) | 0.543 | 0.512 | 0.017 | ||||
| SOD | |||||||
| CTRL | 0.543 | 0.016 | 0.277 | 0.324 | 0.604 | 0.030 | 0.275 |
| QU | 0.003 | 0.094 | 0.115 | 0.263 | 0.007 | 0.093 | |
| CH | 0.0162 | 0.135 | 0.052 | 0.79 | 0.164 | ||
Significant at P<0.05
Figure 1Photomicrographs of liver tissue (section stained with H&E, ×400) (A) CTRL: No visible lesions, (B) QU: Diffuse hydropic degeneration of the hepatocytes with very prominent sinusoids, (C) CH: Marked portal congestion and diffuse vacuolar degeneration of the hepatocytes, (D) CHQU: Mild Kupffer cell proliferation with moderate hepatic vacuolar degeneration, associated with moderate periportal cellular infiltration by mononuclear cells, (E) CHPG(1): Mild congestion of the portal vessels, with very mild periportal, hydropic hepatic degeneration, (F) CHPG(2): Mild portal congestion and mononuclear cellular infiltration, mild periportal and hydropic degeneration, (G) CHSI(1): Marked portal congestion and cellular infiltration by mononuclear cells, (H) CHSI(2): Portal canal congestion moderately infiltrated by mononuclear cells.